PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Gold, Herman K., MD.
Recruitment status was  Active, not recruiting
Guidant Corporation
Information provided by:
Gold, Herman K., MD Identifier:
First received: June 30, 2005
Last updated: May 15, 2007
Last verified: May 2007
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given